Boehringer Ingelheim Pharmaceuticals, Inc.

Last Updated: March 27, 2017

Federal Trade Commission v. Boehringer Ingelheim Pharmaceuticals, Inc.

FTC Matter/File Number:

091 0023

Federal Court:

District of Columbia

Case Timeline

March 27, 2017

application/pdf icon

Federal Trade Commission v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir.), Opening Brief of the Federal Trade Commission, 16-5356 & 16-5357 (consolidated) (412.69 KB)

May 19, 2015

application/pdf icon

FTC v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir.), Response of FTC to Petition for Rehearing En Banc (113.12 KB)

February 20, 2015

application/pdf icon

Opinion for the Court (134.12 KB)

application/pdf icon

Order (49.35 KB)

application/pdf icon

Judgment (63.97 KB)

September 30, 2013

application/pdf icon

FTC v. Boehringer Ingelheim Pharmaceuticals (D.C. Cir.) FTC Brief, 12-5393 (236.19 KB)

application/pdf icon

FTC v. Boehringer Ingelheim Pharmaceuticals (D.C. Cir.) FTC Reply Brief, 12-5393 (129.3 KB)

February 11, 2013

application/pdf icon

Appellant Federal Trade Commissions Opposition to Motion to Dismiss (65.96 KB)

January 14, 2013

application/pdf icon

Appellant Federal Trade Commissions Certificate as to Parties, Rulings, and Related Cases (62.65 KB)

application/pdf icon

Appellant Federal Trade Commissions Statement of Issues to be Raised on Appeal (25.47 KB)

October 27, 2009

application/pdf icon

Proposed Final Order (29.25 KB)

application/pdf icon

Proposed Order to Show Cause (35.98 KB)

application/pdf icon

Petition of the Federal Trade Commission for an Order Enforcing Subpoena Duces Tecum issued in Furtherance of a Law Enforcement Investigation (16 MB)

application/pdf icon

Memorandum in Support of Petition of the Federal Trade Commission for an Order Enforcing a Subpoena Duces Tecum (8.99 MB)

PRESS RELEASE: U.S. Court of Appeals Enforces Subpoenas in FTCs Androgel Investigation; In Separate Case, FTC Files Petition to Compel Enforcement of Subpoena Issued to Boehringer Ingelheim